Market Size (2018)
$4.94B
Vertical: CFnBBase Year: 2018
Market Size (2018)
$4.94B
Projected (2025)
$8.22B
CAGR (2017–2025)
7.5%
Key Players
10+
The demand for organic pesticides has increased over the last few years to meet the high consumer demand for organic food & beverages. Moreover, government authorities and organic trade associations are promoting organic farming which is also anticipated to propel the growth of the global organic pesticides market. However, the high costs of organic pesticides are projected to restrict the growth of the market during the review period.
The Organic Pesticides Market market is projected to grow at a CAGR of 7.5% from 2017 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansPesticides used during the cultivation of organic food are termed as organic pesticides. They can be of two types—natural or synthetic—and need to be used in accordance with the Organic Act of the US Department of Agriculture. The USDA has listed certain ingredients, including microbial strains, minerals, hydrogen peroxide, and soap-based algicide, which can be used in the production of organic pesticides.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Process
Wantstats analysis is based on interviews with industry experts who offer insight into the market structure, market segmentation, technology assessment, competitive landscape (CL), market penetration, as well as the emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and the current market position. Furthermore, the varying trends in segments and categories in each region are studied and estimated based on primary and secondary research.
Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. For this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next five years.
Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global organic pesticides market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, geographical markets, and developments related to the market and technology. For this study, analysts have gathered information from various credible sources such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organizations of chemicals manufacturers, and paid databases.
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the overall organic pesticides market. The key players in the market were identified through secondary research and their market contributions in the respective regions were determined through primary and secondary research. This entire procedure included the study of the annual and financial reports of top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market have been covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated and detailed inputs and analysis added by Wantstats before being presented in this report. The following figure is an illustrative representation of the overall market size estimation process employed for the purpose of this study.
Base Year
2018
Historical Period
2017 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2017–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe global organic pesticides market is highly competitive with key industry players adopting various strategies such as product launches, partnerships, and expansions to strengthen their market positions. Most companies in the market are focused on expanding operations across regions, augmenting their capabilities, and building strong partner relations.
The growth of market players is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving product quality. Andermatt Biocontrol AG, Parry America, Inc., Certis USA LLC, Futureco Bioscience SA, Nufarm, Bayer AG, BASF SE, Sikko Industries Ltd., Vision Mark Biotech, and UPL Limited are the major companies in this market, who compete based on market presence, quality, and price.
Key players are taking steps toward business expansions and entering into untapped markets, thereby increasing their customer bases. The international players may strengthen their presence worldwide through acquisitions during the review period. It has also been forecast that improvements in the global economic scenario and the growing organic pesticides industry in emerging nations would fuel market growth, thereby making it an ideal time for players to launch new products and increase their global market shares.
Threat of New Entrants
The global organic pesticides market is highly competitive and fragmented with the presence of major global and local players. The players in the pesticides market can easily expand their product portfolios to include organic pesticides. Along with this, many local and regional formulators can tap into the market. They procure active ingredients and formulate the products under their brand. Moreover, the manufacturing process is not complicated, and the initial investments required are moderate, which is anticipated to encourage new players to enter the market.
Hence, the threat of new entrants in the global organic pesticides market is expected to be high.
Bargaining Power of Suppliers
The raw material suppliers of organic pesticides are manufactures of microbial strains, chlorine materials, copper sulfate, minerals, hydrogen peroxide, and soap-based algicides. There are several raw material suppliers in the market; organic pesticides manufacturers can easily switch between the suppliers as the switching costs are relatively low. Moreover, the suppliers are not concentrated in any specific region but have a global presence, which is anticipated to decrease their bargaining power.
Hence, the bargaining power of suppliers in the global organic pesticides market is expected to be low.
Bargaining Power of Buyers
There are several buyers in the market who are highly price-sensitive and willing to switch brands based on availability and price. The presence of several brands in the market increases the bargaining power of buyers since their requirements are generic and, thus, can be fulfilled by any brand of organic pesticides.
Hence, the bargaining power of buyers in the global organic pesticides market is expected to be moderate.
Threat of Substitutes
The threat of substitutes for this market is high due to the availability of conventional pesticides. These are economical and highly effective, thereby hindering the growth of the global organic pesticides market. The use of organic pesticides is low due to the limited farmland under organic farming practices, which also enhances the demand for conventional pesticides.
Hence, the threat of substitutes in the global organic pesticides market is expected to be high.
Intensity of Rivalry
The global organic pesticides market is fragmented with the presence of several regional and global players. There is a high level of competition among the market players in terms of product quality and variety. The focus on precision and organic farming has resulted in increased demand for organic pesticides. Moreover, there is a growing number of molecules and active ingredients going off-patent, which is boosting competition in the market.
Hence, the intensity of rivalry in the global organic pesticides market is expected to be high.
Market estimates by geography (2025)
InsightNorth America leads with $2.98B by 2025, while Asia Pacific is projected to grow fastest at a 7.8% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2017 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $980.26M | $1.32B | $1.79B | 7.8% | 22% |
| Rest of the World | $618.24M | $808.38M | $1.06B | 7.0% | 13% |
| Europe | $1.35B | $1.79B | $2.38B | 7.4% | 29% |
| North America | $1.66B | $2.22B | $2.98B | 7.6% | 36% |
| Total | $4.60B | $6.14B | $8.22B | 7.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$8.22B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Natural | $6.08B | 7.6% | 74% |
| Synthetic | $2.14B | 7.2% | 26% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Organic Pesticides Market covering market dynamics, competitive landscape, and strategic outlook.
The Organic Pesticides Market market is projected to reach $8.22B by 2025, growing at 7.5% CAGR. The Natural segment holds the largest share.
The use of organic pesticides is increasing across the globe owing to their advantages over chemical pesticides. Organic pesticides are more effective at controlling pests, have low or negligible residue levels, and assist in retaining soil nutrients unlike chemical pesticides. Government authorities and various regulatory bodies in several countries are promoting the adoption of organic farming, leading to an increase in the sales of organic pesticides. Moreover, the rising demand for organic produce by consumers has influenced farmers to adopt organic farming practices. These factors are collectively driving the growth of the global organic pesticides market. However, the high costs of the pesticides restrict market growth to an extent.
The organic segment of the food industry is growing at a phenomenal rate. Rising health consciousness and consumer inclination toward healthy and nutritional food products are driving the demand for organic food across the globe. Consumers are also concerned about the impact of chemicals on the environment and health, leading to a shift to organically cultivated and processed products. The demand for organic food & beverage, personal care, nutraceutical, and pharmaceutical products is growing, paving the way for the adoption of organic farming. Food processors are highly inclined toward the adoption of natural and organic ingredients to meet the increasing demand for organic products. Moreover, the impressive projected growth of the organic and natural personal care products market from 2018 to 2023 is expected to boost the demand for organic ingredients. As per Wantstats analysis, the global organic and natural personal care products market is projected to register a CAGR of 8.20% during the forecast period of 2018 to 2023. Furthermore, consumers of food supplements tend to be health-conscious and support a healthy lifestyle; they generally prefer organic food supplements. As per the Organic Trade Association, organic food accounted for more than 5% of total food sales in the US in 2017, an increase of 6.4% from the previous year. Consumers are willing to pay a premium for healthy food products, propelling the adoption of organic farming to meet the rising demand.
Thus, the inclination of farmers toward organic farming to meet the rising consumer demand for organic products is driving the growth of the global organic pesticides market.
The increasing demand for organic products across the globe has led small-scale farmers in emerging economies to adopt organic farming practices. Growth is particularly high in emerging economies such as Brazil, India, China, and Argentina owing to rising awareness among farmers about the hazards of chemical fertilizers. There are significant investments being made in organic production in these countries in an effort to shift away from conventional farming practices. In Asia-Pacific, there was a large market for organic consumer goods in Japan and South Korea. However, in recent years, there have been significant developments in China and India. The focus of the agricultural sector in these countries is shifting from exports to domestic consumption. Government support for the promotion of organic farming also plays a significant role. In Thailand, the government launched a large-scale project in 2017 for farmers to receive financial support for buying organic seeds, reducing their dependence on pesticides, and building physical barriers to prevent contamination from neighbouring farmlands. This scheme was launched with the aim to reduce the area of standard rice cultivation by 1m rai (160,000 ha) by 2022.
According to FiBL, in Europe, the largest in-conversion areas in 2017 were in Romania, Poland, Hungary, and Bulgaria. Also, both Russia and Ukraine passed laws for organic claims in 2018 which will create significant opportunities for the suppliers of organic pesticides in these countries. Thus, a shift to organic farming practices in emerging economies offers lucrative growth opportunities to market players.
The organic label is applicable to food or other agricultural products that have been produced using approved methods. The regulatory bodies in different regions such as the US Department of Agriculture (USDA), European Commission, and Agricultural and Processed Food Products Export Development Authority (APEDA) have standards for products with organic claims which are designed to provide a clear structure for the production of organic goods. However, their stringency restricts the implementation of the practice. For instance, the production of organic crops on conventional farmland requires the land to be free of chemicals for a period of five years. Moreover, the certification process in accordance with standards is complex. Significant paperwork is required in order to track each original organic ingredient all the way through production and to the finished product. These factors are expected to restrain the growth of the market during the review period.
Organic farming offers several benefits to farmers; however, adoption of the practice is limited. This can be attributed to the lower costs and higher efficacy of chemical fertilizers and pesticides. Limited awareness, non-availability of organic pesticides, and a lack of guidance from experts are some of the other factors restricting farmers from shifting to organic farming. However, governments and other organizations are taking initiatives to create product awareness through various campaigns. The manufacturers of organic pesticides are also expanding their presence globally, which would aid product availability in developing and underdeveloped countries.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Organic Pesticides Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Company Headquarters: Ahmedabad, Gujrat, India Founded: 1997 Workforce: ~500 Company Working: Sikko Industries Ltd. (Sikko) is a manufacturer of bio agrochemicals, pesticides, and fertilizers. The company offers bio pesticides, herbal pesticides, organic pesticides, seaweed jelly, bio stimulants, and seaweed extracts. It provides processed seeds for fruits and vegetables cultivations and fast-moving consumer goods (FMCG), sprayers, and machineries for farmers. The company was formerly known as Sikko Sprayers & Export Company. Its name was changed to Sikko Industries Ltd in the year 2000.
Nufarm is a mid-cap, Australia-domiciled agricultural inputs company that sits in the "second tier" of global crop protection, below the R&D-led majors (Syngenta, Bayer, Corteva, BASF) and alongside differentiated off-patent specialists such as UPL, ADAMA and Albaugh. Roughly 90% of its A$3.4 billion FY25 revenue comes from crop protection — principally post-patent herbicides (notably phenoxies such as 2,4-D and MCPA, where it is vertically integrated through synthesis plants at Laverton, Australia, and Wyke, UK), fungicides and insecticides, increasingly upgraded through proprietary formulations, mixtures, licensed actives and biologicals. The remaining ~10% is Seed Technologies: a profitable hybrid seeds franchise (canola, sorghum, sunflower) with a southern-hemisphere bias, plus two emerging platforms — plant-based omega-3 canola oil and carinata biofuel feedstock — that are strategically distinctive but have been capital-hungry. After a difficult FY24–FY25, the company is executing a cost, capital and portfolio reset under a new CEO. --- ### Company's own description (paraphrased from AR25) Nufarm describes itself as a global crop protection and seed technologies company helping farmers and businesses meet the challenges of food, feed, fibre and fuel production, leveraging agility, capabilities and partnerships. It cites a 3,000+ workforce across nearly 50 countries and partnerships with universities, suppliers and innovation partners. Customers are primarily agricultural distributors and growers, and more recently the aquaculture, nutrition and bioenergy industries (AR25, "About us"). Crop protection comprises the majority of the business. The AR25 "Where we play" framework organises the company into: - **Crop protection platforms:** core crop protection, integrated solutions, biologicals, emerging solutions. - **Seed technologies platforms:** hybrid seeds, nutritional (omega-3), bioenergy (carinata, energy cane). - **Core crops:** cereals; trees, nuts, vines & vegetables (TNV); corn; soybean; pasture, turf & ornamental. - **Core seeds:** sorghum, sunflower, canola, carinata, energy cane. - **Key regions:** North America, Europe, APAC, South America (the latter now seeds-only following the 2020 sale of South American crop protection to Sumitomo). ### Independent characterisation Nufarm is best characterised as a formulator-marketer of predominantly off-patent crop protection chemistry with selective backward integration (phenoxy herbicide synthesis) and a capital-light innovation model that relies on licensing and co-development (e.g., Sumitomo Chemical, FarmHannong, ISK, KingAgroot, Agrauxine) rather than discovery of new active ingredients. Its competitive edge rests on regulatory dossiers and registrations (a significant barrier, especially in the EU), channel relationships, formulation know-how and route-to-market density in Australia, North America and Europe. The seeds business is structurally different: IP-rich hybrid genetics with licensing revenue, and two speculative platforms that depend on regulatory deregulation (omega-3 canola for consumption in the EU and China, targeted 2028) and policy-driven biofuel demand (SAF / renewable diesel mandates and GHG credit values). ### Value-chain position - **Upstream:** Procures active ingredients and intermediates, heavily from China (global procurement hub in Shanghai). Synthesises select actives (phenoxies at Laverton and Wyke). - **Midstream:** Formulates at 11 manufacturing sites globally (being reduced via the Kwinana and Alsip closures). - **Downstream:** Sells through distributors and retailers; Croplands sells spray application equipment in Australia/NZ; the Turf & Ornamental channel serves golf courses, landscapers and specialty users in North America. - **Seeds:** Breeding and trait development (innovation centres in Horsham, Sacramento and Venado Tuerto); seed production; carinata grower contracting in South America with oil offtake to bp.
UPL Limited is India's largest agrochemical company by revenue and one of the world's five largest crop-protection players, with FY26 consolidated revenue of ₹51,839 crore (≈US$5.9bn) and a presence in more than 140 countries. Its distinctive model blends a low-cost, backward-integrated Indian manufacturing base for off-patent active ingredients with a global formulation, registration and distribution network built largely through the 2019 acquisition of Arysta LifeScience. The group is organised into four "pure-play" platforms: UPL Corporation (international crop protection), UPL SAS (India crop protection), Advanta (global hybrid seeds and post-harvest) and SUPERFORM (active ingredients and specialty chemicals). Over 2024–2026 UPL has executed a deleveraging programme — rights issue, Advanta minority sales, US$850m gross debt reduction in FY26 — and launched a simplification restructuring creating UPL Global, alongside a pending Advanta IPO. The equity, however, trades near multi-year lows on leadership turnover, holdco discount and execution concerns. --- ### What UPL does UPL manufactures, formulates, registers and sells crop-protection products (herbicides, insecticides, fungicides, plant-growth regulators, seed treatments), biosolutions branded under "Natural Plant Protection" (NPP), hybrid seeds (field corn, sunflower, sorghum, canola, rice, vegetables), post-harvest solutions (fruit coatings, fungicides and storage treatments under the Decco brand), and industrial/specialty chemicals including active ingredients sold to third parties. The company's own description (Q1 FY27 press release, 3 Aug 2026) presents UPL as a global provider of sustainable agricultural products and solutions spanning the whole agrifood value chain, organised through four pure-play platforms: UPL Corporation Ltd, UPL Sustainable Agri Solutions Ltd (UPL SAS), Advanta Enterprises Ltd and SUPERFORM Chemistries Ltd (formerly UPL Speciality Chemicals Ltd). ### Business model UPL's economic engine is the post-patent (generic) agrochemical model, enhanced with differentiation: 1. **Backward integration in India**: Gujarat-based plants manufacture technical-grade active ingredients (AIs) and intermediates at low cost; SUPERFORM supplies both UPL's own crop-protection platforms and third parties. 2. **Global registration moat**: Thousands of product registrations across Latin America, North America, Europe and Asia — inherited and expanded via Arysta — create barriers for pure generic exporters. In FY26 UPL Corp launched 300+ new products generating US$160m+ revenue from new launches (FY26 earnings presentation). 3. **Differentiated and sustainable portfolio**: Combination products, proprietary mixtures, biosolutions (NPP) and "ProNutiva" seed-to-harvest programmes. Management expects ≈US$700m of FY27 revenue from the sustainable solutions portfolio (Q1 FY27 call). The FY25 sustainability report states 38% of revenue came from differentiated and sustainable solutions. 4. **Seeds**: Advanta breeds and sells locally adapted hybrids with 900+ varieties across 21 breeding crops, distributed in 74 countries (Advanta DRHP, as of 30 Sep 2025). 5. **Distribution and channel credit**: Sales go through distributors, retailers and co-operatives; extended credit terms (notably in Brazil) make working capital a central management variable. ### Revenue model mix UPL is overwhelmingly a product business. There is no material subscription or licensing revenue disclosed. Approximate FY26 platform mix (gross, before inter-segment eliminations; FY26 earnings release): Note: Platform revenues sum to more than consolidated revenue because SUPERFORM sells AIs to the crop-protection platforms (eliminated on consolidation). Management stated non-agchem revenue share is roughly 27% (Q3 FY26 press release). ### Value chain position UPL spans: intermediates → technical AI manufacture (SUPERFORM) → formulation (India and international plants) → registration and regulatory dossiers → branded distribution to growers; plus germplasm/breeding → seed production → seed sales (Advanta); and post-harvest treatments for fruit and vegetable packers (Decco). ### Customer types and end-markets ### Independent characterisation UPL is best understood as a leveraged, emerging-market-origin consolidator of the global off-patent crop-protection market that is in transition toward a holding-company structure with separately listed operating assets. Its competitive edge is cost and registration breadth rather than discovery chemistry; its key weaknesses are cyclicality (the 2023–24 channel destocking cut revenue 20% and produced a loss), high financial leverage relative to rated peers (sub-investment-grade at the UPL Corp level), and governance perceptions tied to complex inter-company structures. The 2026 restructuring (UPL Global) and the Advanta IPO are explicit attempts to remedy the conglomerate discount — DAM Capital estimates the holdco discount at ~61% (Aug 2026).
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
Company Headquarters: Pune, Maharashtra, India Founded: 2012 Workforce: ~30 Company Working: Vision Mark Biotech (Vision) is a multidimensional biotech company, which provides safe and cost-effective, high-quality biotechnology-based products and services to customers. The company is a manufacturer, supplier, wholesaler and service provider of bioorganic fertilizers, biopesticides, supplementary products, tissue culture plants, effective microorganism solutions, soil testing services, water testing services, and microbial testing services.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)